Hydroxyapatite (CaHA)
A core foundational material for bone repair, aesthetic medicine, scientific research and development, and other high-end application scenarios.
View DetailsNanjing Junzhuo Biotechnology Co., Ltd. specializes in the R&D, manufacturing, and application support of advanced hydroxyapatite and bioceramic materials. We are committed to delivering highly stable and specialized material solutions for orthopedic reconstruction, medical aesthetic injectables, surface coatings, and translational research.
A core foundational material for bone repair, aesthetic medicine, scientific research and development, and other high-end application scenarios.
View Details
Beta tricalcium phosphate (β-TCP) is a high-performance bioceramic material with biomimetic mineral characteristics.
View Details
Centered on material directions such as biphasic calcium phosphate, calcium silicate, and calcium sulfate hemihydrate, we continue to advance the in-depth development of new bioceramic materials.
View DetailsAcross key dimensions such as particle size distribution, morphology, packaging format, and application documentation, we support custom development from requirement communication and sample validation to project onboarding.
View DetailsNanjing Junzhuo Biotechnology Co., Ltd. focuses on the research, production, and custom development of high-end biomaterials, providing professional material solutions for customers worldwide.
About Junzhuo
The latest updates on company developments, technical articles, and industry content.
A 2026 in vitro study compares HAp/CuO and HAp/ZnO for inhibition zones, Vickers microhardness, and L929 cell viability.
A Ca/P ratio near 1.67 is a useful compositional clue, but confirming hydroxyapatite also requires bulk chemistry, XRD, FTIR, and crystallinity data.
A 2026 single-center randomized study compared fractional CO₂ laser alone with the same laser followed by a defined CaHA suspension prepared with non-crosslinked HA; its findings apply to that combination only.